Finally Covaxin Phase 3 results are out in a Pre Print  publication 


Looks Good, details awaited


Overall efficacy : 77.8 %  

Against Delta : 65.2 % 

Against severe infections: 93.4%

Asymptomatic  infections : 63.6 %

Comments

Popular posts from this blog